Evidence map›Paper›PMID 35265255›Full record

ArticleInternational journal of clinical and experimental pathology2022

Pleomorphic high grade endometrial stromal sarcoma with

Asad Ullah, Haritha Arbindi, Francis Zola, Samantha Nieves Mattox, Luis Velasquez Zarate, Janet Munroe, Saleh Heneidi, Suash Sharma, Sharad Ghamande, Daniel T Kleven

Open access · greenAbstract readCase Reports
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. High-grade endometrial stromal sarcoma withInternational journal of clinical and experimental pathology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Asad UllahDepartment of Pathology, Medical College of Georgia Augusta, GA 30912, USA.
Haritha ArbindiMedical College of Georgia Augusta, GA 30912, USA.
Francis ZolaMedical College of Georgia Augusta, GA 30912, USA.
Samantha Nieves MattoxDepartment of Pathology, Medical College of Georgia Augusta, GA 30912, USA.
Luis Velasquez ZarateDepartment of Pathology, University of Texas Medical Branch Galveston, TX 77555, USA.
Janet MunroeDepartment of Radiology, Medical College of Georgia Augusta, GA 30912, USA.
Saleh HeneidiDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center Los Angeles, CA 90048, USA.
Suash SharmaDepartment of Pathology, Medical College of Georgia Augusta, GA 30912, USA.
Sharad GhamandeDepartment of Obstetrics and Gynecology, Medical College of Georgia Augusta, GA 30912, USA.
Daniel T KlevenDepartment of Pathology, Wake Forest Baptist Health Winston-Salem, NC 27157, USA.
Augusta University · USAtrium Health Wake Forest Baptist · USCedars-Sinai Medical Center · USThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial stromal neoplasms are classified by the World Health Organization (WHO) into endometrial stromal nodule (ESN), low grade (LGESS), high grade (HGESS), and undifferentiated uterine sarcoma (UUS). HGESS is subclassified based on molecular findings,

Indexed as

High-grade endometrial stromal sarcomapleomorphicYWHAE amplification

Identifiers

PMID35265255
PMCPMC8902479
OpenAlexW4226225608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.